Gedeon Richter (UK) Limited

What Gedeon Richter (UK) Limited does

Gedeon Richter (UK) Limited is the United Kingdom operating subsidiary of Gedeon Richter Plc., a Hungarian-headquartered, publicly listed specialty pharmaceutical group founded in 1901 by the pharmacist Gedeon Richter. The UK entity operates as a private limited company and is part of a vertically integrated multinational whose activities span pharmaceutical manufacturing, research and development, sales, and marketing. The group's stated objective is to help patients manage illness through innovative products with the aim of improving quality of life.

The company's commercial offering centres on a Women's Healthcare Portfolio that covers contraception and emergency contraception, fertility, heavy menstrual bleeding, hormone replacement therapy, osteoporosis, uterine fibroids, and topical local anaesthetic. Two additional product lines — OTC products and wholesale products — extend distribution beyond prescription channels. Three areas of expertise underpin the portfolio: Women's Healthcare (the primary therapeutic focus), Original Research (proprietary drug development), and Biotechnology (initiated in 2006 as a core element of the group's R&D strategy).

Commercial operations run through a vertically integrated sales and marketing function supported by wholesale distribution and OTC retail channels. A referenced relationship with Medimpex UK suggests the use of a channel partner for UK distribution. The UK corporate website (gedeonrichter.com/uk) serves as the primary digital presence and surfaces extensive sustainability and transparency disclosures, including drug safety, quality management, responsible marketing, transfer-of-value reporting to patient organisations, adverse event reporting, environmental protection, and a UK Green Commitment. The group claims presence in over 100 countries, multiple manufacturing facilities, representative offices, and subsidiaries globally, providing scale economies that underpin the UK entity's market position.

Name

Gedeon Richter (UK) Limited

Legal name

Gedeon Richter UK Limited

Website

https://gedeonrichter.co.uk

Company type

Private

Founded year

1901

Operating status

Operating

Headcount range

51–100 employees

Short description

Gedeon Richter (UK) Limited is the UK subsidiary of Hungarian pharmaceutical group Gedeon Richter Plc., distributing a vertically integrated women's healthcare portfolio — contraception, fertility, HRT, and related therapies — alongside OTC and wholesale products to UK prescribers and patients.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals (Women's Healthcare)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

Keywords

• Women's healthcare pharmaceuticals
• Prescription medicines
• Original drug research
• Biopharmaceutical development
• Hormone replacement therapy

Headquarters

HQ city

Maida Vale, London, England

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Revenue generated from manufacturing and selling specialty pharmaceutical products including prescription medicines and OTC products through vertically integrated operations spanning manufacturing, R&D, sales and marketing.

Distribution channels2 records

Marketing channels1 record

Core offering

Gedeon Richter (UK) Limited is a UK-incorporated specialty pharmaceutical company that, as part of the Gedeon Richter group, develops, manufactures, and sells pharmaceutical products — primarily a Women's Healthcare Portfolio covering contraception, fertility, heavy menstrual bleeding, hormone replacement therapy, osteoporosis, uterine fibroids, and topical local anaesthetic — together with OTC products and wholesale pharmaceutical lines. The group operates a vertically integrated value chain spanning research and development, pharmaceutical manufacturing, and sales and marketing, with a presence in over 100 countries.

Product overview

Gedeon Richter is a specialty pharmaceutical company with a vertically integrated business model encompassing pharmaceutical manufacturing, research and development, and sales and marketing. The company operates three core areas of expertise: Women's Healthcare, Original Research, and Biotechnology. The Women's Healthcare Portfolio is the company's primary therapeutic focus, comprising seven sub-product categories spanning contraception, fertility, heavy menstrual bleeding, hormone replacement therapy, osteoporosis, uterine fibroids, and topical local anaesthetic. The portfolio also includes OTC products and wholesale products. The biotechnology business was initiated in 2006 as a key element of the company's R&D strategy.

Differentiator

Problem solved

Functional benefit

Products and services

• Women's Healthcare Portfolio

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Medimpex UKminorChannel Partner/ Reseller/ DistributorMedimpex UK is referenced as a related entity in the footer of the Gedeon Richter UK website. Medimpex UK appears to serve as a distribution or commercial partner for Gedeon Richter products in the UK market, with a link provided for additional information.

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Direct peers

• Organon & Co. Publicly traded specialty pharmaceutical company spun out of Merck focused explicitly on women's health, with a portfolio spanning contraception, fertility, and menopause treatments. Directly comparable in therapeutic focus and product categories to Gedeon Richter's women's healthcare portfolio.
• Bayer Pharmaceuticals (Women's Health): Major global pharmaceutical company with a long-established women's health franchise including contraception, HRT, and fertility treatments. Comparable in product categories and regulatory scope to Gedeon Richter's women's healthcare offerings.
• Theramex: Specialty pharmaceutical company dedicated to women's health, with a portfolio covering contraception, HRT, menopause, and reproductive health. Closely comparable in therapeutic focus and target customer segments.
• Gedeon Richter Plc. Hungarian parent company of Gedeon Richter UK Limited, with global vertically integrated operations spanning manufacturing, R&D, and commercialization in women's health, biosimilars, and original drug research. The UK entity is a direct operational unit of this group.

Broad incumbents

• Pfizer Inc. Global pharmaceutical leader with a substantial women's health and biosimilars portfolio as part of its broader specialty offerings. Comparable as a large incumbent competing in the same therapeutic categories including HRT and reproductive health.
• Teva Pharmaceutical Industries: Global specialty and generic pharmaceutical company with significant women's health and biosimilars presence. Comparable as a broad incumbent with overlapping capabilities in specialty pharma and biosimilars, though operating across many therapeutic areas beyond women's health.
• AbbVie Inc. Global pharmaceutical company with specialty franchises including women's health, neuroscience, and immunology. Comparable as a broad incumbent with overlapping capabilities in branded specialty pharmaceuticals and complex manufacturing.
• Stada Arzneimittel AG: European specialty and generics pharmaceutical company with a women's health portfolio alongside broader product lines. Comparable as a European-headquartered specialty pharma player with overlapping portfolio and distribution channels.
• Merck KGaA (Healthcare): German multinational pharmaceutical and life sciences company with a specialty pharma franchise and significant biosimilars business. Comparable as a European-headquartered specialty pharmaceutical peer with overlapping R&D and manufacturing capabilities.

Emerging players

• Polpharma Biologics: Biosimilars-focused pharmaceutical company with overlapping biotechnology and specialty pharma capabilities. Comparable as an emerging player in biosimilars and complex therapeutics intersecting with Gedeon Richter's biotechnology vertical.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/gedeon-richter-uk

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gedeon Richter (UK) Limited